🇺🇸 Diclofenac, topical in United States

23 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 3 reports (13.04%)
  2. Hypotension — 3 reports (13.04%)
  3. Keratopathy — 3 reports (13.04%)
  4. Blood Creatinine Increased — 2 reports (8.7%)
  5. Bradycardia — 2 reports (8.7%)
  6. Condition Aggravated — 2 reports (8.7%)
  7. Deep Vein Thrombosis — 2 reports (8.7%)
  8. Diarrhoea — 2 reports (8.7%)
  9. Drug Interaction — 2 reports (8.7%)
  10. Fall — 2 reports (8.7%)

Source database →

Other Pain Management / Rheumatology approved in United States

Frequently asked questions

Is Diclofenac, topical approved in United States?

Diclofenac, topical does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Diclofenac, topical in United States?

Nuvo Research Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.